{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:06:39Z","timestamp":1781834799885,"version":"3.54.5"},"reference-count":23,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/03007995.2021.1965975","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T07:53:46Z","timestamp":1628841226000},"page":"1761-1768","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-na\u00efve subjects"],"prefix":"10.1080","volume":"37","author":[{"given":"Dimos D.","family":"Mitsikostas","sequence":"first","affiliation":[{"name":"1st Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Dekundy","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hanschmann","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Althaus","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-0853","authenticated-orcid":false,"given":"Astrid","family":"Scheschonka","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Pagan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Georgetown University Hospital Pasquerilla Healthcare Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-3674","authenticated-orcid":false,"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23658"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-0998-9"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0323-3"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110107"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/BF00941758"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.11.003"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000110"},{"key":"CIT0009","volume-title":"XEOMIN (incobotulinumtoxin A) for injection, for intramuscular or intraglandular use","author":"Highlights of Prescribing Information","year":"2019"},{"key":"CIT0010","unstructured":"Xeomin 200 units powder for solution for injection. Herts (UK): Merz Pharmaceuticals UK Ltd; 2020 Jan 29. [cited 2020 Mar 19]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2162\/smpc."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050332"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002560"},{"key":"CIT0013","volume-title":"BOTOX cosmetic (onabotulinumtoxinA) for injection, for intramuscular use","author":"Highlights of prescribing information","year":"2019"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.05.033"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10217-7"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13010042"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.08.004"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01427-6"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22368"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0529-x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1278-z"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S141060"},{"key":"CIT0023","unstructured":"US Food and Drug Administration. Supplement approval. 2019 May 10. [cited 2020 Sep 30]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2019\/125360Orig1s074ltr.pdf."}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2021.1965975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:36:31Z","timestamp":1650544591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2021.1965975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/03007995.2021.1965975"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2021.1965975","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}